Artificial intelligence in oncology
Artificial intelligence (AI) is becoming part of everyday life, and it’s beginning to shape the future of cancer care too.
From how we interpret scans to how treatments are planned and monitored; AI has the potential to support more personalised, timely and effective care.
As these technologies evolve, it’s essential they are used to enhance, not replace, the human connection at the heart of medicine.
While AI is not yet fully embedded in day-to-day practice, many clinicians are already using AI-enabled tools such as advanced imaging, digital pathology and clinical decision-support systems.
Importantly,
these technologies are designed to support clinicians - not replace clinical judgementhelping refine care while keeping patients at the centre.
AI’s greatest promise lies in analysing large, complex data sets to identify patterns that may otherwise be missed.
In time, this could help detect treatment complications earlier, predict responses to therapy, and better understand real-world patient outcomes, including for older, frailer and more diverse patients often underrepresented in clinical trials.
At Icon, our unified electronic medical record provides a strong foundation for using AI responsibly and ethically. By combining innovation with compassion, we are working toward a future where technology supports better outcomes without losing the human touch.
This article is a shortened version of a longer piece written by Associate Professor Louise Nott, a medical oncologist at Icon Cancer Centre Hobart and Icon Group Director of Medical Oncology across Australia and New Zealand.
Read more: qrco.de/icfinsightautumn2026
Research driving better care for patients
Icon Cancer Foundation’s latest research grants are supporting three new studies aimed to improve treatment outcomes and reduce side effects for people living with cancer.
One project is exploring how artificial intelligence can securely capture information from routine appointments, helping doctors learn from every patient experience and improve care without adding to clinical workload.
Another is developing a dedicated database for advanced cellular therapies, including stem cell transplants and CAR-T cell therapy. By tracking outcomes more closely, clinicians can better understand what works and continue improving care for patients receiving these complex treatments.
The third study focuses on breast cancer radiation, ensuring that newer surgical techniques continue to work alongside treatments known to reduce the risk of cancer returning.
Together, these projects are bringing research and care closer together, helping insights translate into meaningful benefits for patients sooner.
Thank you to our generous donors for making this vital research possible.
Read more: qrco.de/icfinsight-autumn2026
Connecting with the community
10km for $10K
The Greater Springfield community (Queensland) united for the 10km for $10k fun run, raising over $16,000 for cancer research. Organised by Harcourts Greater Springfield and inspired by Icon Cancer Centre patient Rudy Grommen’s cancer journey, more than 95 runners and walkers surpassed the goal, showing extraordinary community spirit and support for patients and families.
Read more:
qrco.de/icfinsight-autumn2026
Long Lunch funds lifesaving care
Ray White New Farm has hosted the annual Long Lunch, bringing friends and community together to make a difference. In the past two years, Icon Cancer Foundation has received over $120,000 to support blood cancer research and fund a dedicated cellular therapy coordinator, directly helping patients.
Read more: qrco.de/icfinsight-autumn2026
Cycling challenge supports cancer research
The Hutchies 1-Day Crit Challenge Ride will be back this year in August - bigger, better and even more exciting!
How can I say thank you?
The Hutchies 1-Day Crit Challenge Ride was a remarkable success, raising an incredible $250,000 to support cancer research through Icon Cancer Foundation (ICF) and early intervention services for children with autism via AEIOU Foundation.
Late last year, 48 dedicated cyclists took on the Nundah crit track (Brisbane), conquering 250km amid soaring temperatures, cheered on by family, friends, and supporters. The energy around the track was electric, filled with camaraderie, generosity and spirited competition.
One of the day’s most inspiring moments was seeing Icon Cancer Centre clinicians ride alongside current and past patients, symbolising resilience, strength and hope.
This special collaboration was inspired by Associate Professor James Morton AM, Icon Group’s Director of Haematology and Founder of AEIOU Foundation, alongside Hutchinson Builders Managing Director Russel Fryer, uniting both foundations in a shared mission to support families navigating complex health journeys.
Together, riders covered 4,569km, completing 3,808 laps of the circuit.
A heartfelt thank you goes to Hutchinson Builders, AEIOU Foundation, volunteers and participants.
Read more: qrco.de/icfinsight-autumn2026
We often hear this question. Now, patients and their families can easily let your Icon care team know they’ve made a difference.
Leave a message on our Grateful Patient portal and - if you wish, support Icon Cancer Foundation. Find out more.
